Silo Pharma (SILO) shares were down 10% in recent premarket activity on Thursday, a day after the company began trading on Nasdaq on a split-adjusted basis.
The company said earlier this week that it has completed a 1-for-15 reverse stock split of its issued, outstanding, and authorized common shares, effective June 2.